eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | basal cell nevus syndrome |
| Comorbidity | C0007117|basal cell carcinoma |
| Sentences | 10 |
| PubMedID- 21668511 | Conclusion: methylaminolevulinate-photodynamic therapy seems an interesting option for the treatment of basal cell carcinomas in patients with basal cell nevus syndrome. |
| PubMedID- 26473628 | Novel treatments that target the oncogenic hedgehog signalling pathway are revolutionising the treatment of cutaneous basal cell carcinoma (bcc) in patients with naevoid basal cell carcinoma syndrome (nbccs). |
| PubMedID- 25148279 | Axillary basal cell carcinoma in patients with goltz-gorlin syndrome: report of basal cell carcinoma in both axilla of a woman with basal cell nevus syndrome and literature review. |
| PubMedID- 21965847 | Comparison of risk factors of single basal cell carcinoma with multiple basal cell carcinomas. |
| PubMedID- 22805146 | basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient. |
| PubMedID- 23036338 | A phase ii, randomized, placebo-controlled trial in gorlin syndrome patients with basal cell carcinoma concluded that vismodegib was significantly better than placebo at reducing new basal cell carcinoma lesions (p < 0.001) and at decreasing the sum of the longest diameter of existing lesions (p = 0.003). |
| PubMedID- 23277178 | Metastasis of basal cell carcinoma in a patient with basal cell carcinoma syndrome. |
| PubMedID- 24698937 | Goltz-gorlin syndrome presents with multiple basal cell carcinomas, odontogenic keratocysts, and cutaneous cysts, among other manifestations. |
| PubMedID- 20500542 | Temporary arrest of basal cell carcinoma formation in a patient with basal cell naevus syndrome (bcns) since treatment with a gel containing various plant extracts. |
| PubMedID- 24898076 | Importance: basal cell carcinomas (bccs) in patients with gorlin syndrome have been reported to be extremely sensitive to smoothened (smo) inhibitors, a novel targeted therapy against the hedgehog pathway, because of characteristic mutations in these patients. |
Page: 1